Comparison of two different methods for cardiovascular risk assessment: Framingham risk score and SCORE system

Journal of Medical Biochemistry

Volumn 26, Issue 2, 2007, Pages 94-97

  Jovičić, Snežana ^a   Ignjatović, Svetlana ^a   Majkić Singh, Nada ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Cardiovascular disease; Framingham risk score; Risk assessment; SCORE

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALGORITHM; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE;

EID: 34249282388     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-007-0012-x     Document Type: Article

References (14)

1. Smith SC, Milani RV, Arnett DK, Crouse JR III, McGraeMcDermott M, Ridker PM, et al. Atherosclerotic vascular disease conference. Writing group II: Risk factors. Circulation. 2004; 109: 2613-16.
2. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003; 290: 898-904.
3. Greenland P, Smith SC, Grundy SC. Improving coronary heart disease risk assessment in asymptomatic people: Role of traditional risk factors and noninvasive cardiovascular tests. Circulation. 2001; 104: 1863-7.
4. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart-disease using risk factor categories. Circulation. 1998; 97: 1837-47.
5. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K, et al. Prevention of coronary heart disease in clinical practice: Recommendations of the Third Joint Task Force of European and other societies on coronary prevention. Atherosclerosis. 1998; 140: 199-270.
6. Greenland P, Grundy SM, Pasternak RC, Lenfant C. Problems on the pathway from risk assessment to risk reduction. Circulation. 1998; 97: 1761-2.
7. Grundy SM, Pasternak RC, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple risk factor assessment equation. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation; 1999: 1481-92.
8. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA; 285: 2486-97.
9. De Backer G, Ambrosioni E, Borch-Johnsen K, Brontos C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other societies in cardiovascular disease prevention in clinical practice. Executive Summary. Eur Heart J. 2003; 24: 1601-10.
10. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24: 987-1003.
11. National Cholesterol Education Program. Risk assessment tool for estimating 10-year risk of developing hard CHD (myocardial infarction and coronary death). http://hin.nhlb.nih.gov/atpiii/calculator.asp?usertype=prof (accessed January 10, 2007).
12. Topol EJ, Lauer MS. The rudimentary phase of personalised medicine: coronary risk scores. Lancet. 2003; 362: 1776-7.
13. D'Agostino RB, Grundy SM, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic group investigation. JAMA. 2001; 286: 180-7.
14. Zamaklar M. Konsenzus konferencija o promeni referentnih vrednosti lipida i ciljnim vrednostima lečenja lipidskih poremećaja. Jugoslov Med Biohem. 2005; 24: 299-300.